Mankind Pharma shares hit fresh 52-week high - Buy, Sell or Hold? Check target

Mankind Pharma Share Price: The share price of Mankind Pharma, an Indian pharmaceutical and healthcare products company, surged over 5 per cent in the morning trade. At around 11:48 am, shares of Mankind Pharma were up 4.97 per cent or Rs 106.95 at Rs 2257.45.

Earlier, it went up by 5.09 to hit an intraday high of Rs 2,260, which is also the new 52-week high. 

According to Kunal Saraogi of Equityrush, investors should buy this pharma stock at every dip. 

"There's a fresh breakout in the chart of Mankind Pharma. So we would advise investors to buy from a medium to long-term perspective. Investors should buy when there is some correction. Keep on accumulating the share whenever there is some dip in the price,"  Saraogi said.

According to market expert Rakesh Bansal, the share can achieve the target of Rs 2,600 in the next 3-4 months.

"Rs 2,150-2,180 is a good zone to buy when prices dip. Our target is 2,600 in the time horizon of 3-4 months," Bansal said.

Meanwhile, benchmark equity indices climbed in early trade amid a rally in global markets. The 30-share BSE Sensex jumped 341.76 points to 71,999.47 in early trade. The Nifty climbed 107.8 points to 21,726.50.

In Asian markets, Seoul, Tokyo, Shanghai and Hong Kong were trading with gains. The US markets ended in positive territory on Wednesday.

On Wednesday, the BSE benchmark ended 271.50 points or 0.38 per cent higher at 71,657.71. The Nifty advanced 73.85 points or 0.34 per cent to 21,618.70.